Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DR26FDKT1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,798
Award facts
- Contract value 100% obligated
- $29,797.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order with a ceiling value of $29,797.50 to DMS Pharmaceutical Group Inc., a woman-owned small business, on July 27, 2026, for Entyvio 300 MG vials. The order is firm fixed price, carries an ultimate completion date of July 28, 2026, and was issued with no set-aside. Place of performance is Park Ridge, Illinois.
Quick answers
Who was awarded contract SPE2DR26FDKT1?
SPE2DR26FDKT1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 27, 2026.
How much is contract SPE2DR26FDKT1 worth?
The government has obligated $29,798 on SPE2DR26FDKT1.
Is contract SPE2DR26FDKT1 an order under another contract?
Yes. SPE2DR26FDKT1 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDKT1 competed?
The extent of competition for SPE2DR26FDKT1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award